Justice Department eases restrictions on some marijuana products
Summary
The Justice Department has lowered the drug classification for some marijuana products, moving FDA-approved and state-licensed medical marijuana items to Schedule III. This change is intended to help research and improve medical treatment options for patients.Key Facts
- The Justice Department issued an order to reschedule certain marijuana products.
- FDA-approved marijuana products and those under state medical licenses are now in Schedule III.
- Schedule III is a lower classification under the Controlled Substances Act, meaning less strict rules.
- Acting Attorney General Todd Blanche signed the order.
- The change supports more research on marijuana’s safety and effectiveness.
- This action follows President Donald Trump’s December executive order to begin rescheduling marijuana.
- Rescheduling aims to provide better care for patients and more reliable information for doctors.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.